Related Experiment Videos
The phenylpropionic acid load test: experience with 72 children at-risk for beta-oxidation disorders
J F Glasgow1, R Moore, P H Robinson
1Department of Child Health, Queen's University of Belfast, U.K.
Irish Journal of Medical Science
|October 1, 1992
Summary
Phenylpropionic acid (PPA) metabolite excretion in urine peaks within 3 hours after oral administration. This finding supports PPA loading tests as a diagnostic tool for medium acyl CoA dehydrogenase deficiency in at-risk children.
Area of Science:
- Biochemistry
- Pediatric Medicine
- Metabolic Disorders
Background:
- Medium acyl CoA dehydrogenase deficiency is a serious metabolic disorder.
- Children at risk often present with Reye Syndrome or Reye-like symptoms.
- Investigating inborn errors of metabolism requires reliable diagnostic tests.
Purpose of the Study:
- To evaluate the diagnostic utility of phenylpropionic acid (PPA) loading tests.
- To determine the optimal urine collection window for PPA metabolite analysis.
- To assess PPA loading as a safe and effective diagnostic method for at-risk children.
Main Methods:
- Oral administration of phenylpropionic acid (PPA) to 72 children (2 days to 16 years).
- Urine collection and analysis of PPA metabolites.
- Study population included children with Reye Syndrome, Reye-like syndrome, and siblings of affected individuals.
Main Results:
- Urinary excretion of PPA metabolites is maximal within 3 hours post-administration.
- This 3-hour urine collection window is identified as diagnostic.
- PPA loading is confirmed as a simple and safe investigative procedure.
Conclusions:
- Phenylpropionic acid (PPA) loading test is a valuable diagnostic tool for medium acyl CoA dehydrogenase deficiency.
- The 3-hour post-load urine collection is crucial for accurate diagnosis.
- This method aids in the early identification of inborn errors of metabolism in pediatric patients.